After the legalization of marijuana in the U.S., many companies are actively engaged in the research, development and distribution of cannabis. Cannabidiol (CBD) is the non-psychoactive substance ...

Cannabidiol (CBD) holds promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain. Few studies ...

The FDA does not approve CBD products, so it’s up to consumers to sort out good from bad as they shop for CBD. Many CBD products are not accurately labeled, so it’s important to choose a product that ...

If neuropathy stems from a treatable condition, such as diabetes, chronic alcohol use disorder, or nutrient deficiencies, a doctor will aim to manage the condition first. Neuropathy is often used ...

You can’t underestimate the overall impact of High Times in the world of printed media and counterculture over the decades. It unapologetically pushed the envelope of what publishers could get away ...

The best CBD brands have a positive reputation; all their products undergo third-party testing. They also offer a wide range of products and are very clear about dosage and ingredients. The brands we ...

Jessica is a writer, editor and media professional who has spent her career working with some of the most influential names in media. Prior to joining Forbes Health, Jessica was the manager of ...

What's really behind the CBD craze? Consumer Reports' video team dug deep, talking with a runner in Maine who says it eases the pain of her marathon training, and a military vet in Minnesota who says ...

For decades, oil was the defining force that powered the Gulf's economies, shaping trade flows, political influence, and long-term wealth. But as the region pivots toward diversification, digital ...

Forbes contributors publish independent expert analyses and insights. Gaurav Sharma is a London-based analyst who covers energy & ESG.